Evidence map›Paper›PMID 27872203›Full record

ReviewEMBO reports2016

Molecular mechanisms of asymmetric divisions in mammary stem cells.

Angela Santoro, Thalia Vlachou, Manuel Carminati, Pier Giuseppe Pelicci, Marina Mapelli

Open access · bronzeAbstract readReview
In one paragraph

Review in EMBO reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The CRL7Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Asymmetric division of stem cells and its cancer relevance.Cell regeneration (London, England) · 2024
    Review
  9. Frontiers in cell and developmental biology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Tracing the developmental origin of tissue stem cells.Development, growth & differentiation · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Angela SantoroDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Thalia VlachouDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Manuel CarminatiDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Pier Giuseppe PelicciDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy piergiuseppe.pelicci@ieo.eu marina.mapelli@ieo.eu.
Marina MapelliDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy piergiuseppe.pelicci@ieo.eu marina.mapelli@ieo.eu.ORCID 0000-0001-8502-0649
European Institute of Oncology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells have the remarkable ability to undergo proliferative symmetric divisions and self-renewing asymmetric divisions. Balancing of the two modes of division sustains tissue morphogenesis and homeostasis. Asymmetric divisions of Drosophila neuroblasts (NBs) and sensory organ precursor (SOP) cells served as prototypes to learn what we consider now principles of asymmetric mitoses. They also provide initial evidence supporting the notion that aberrant symmetric divisions of stem cells could correlate with malignancy. However, transferring the molecular knowledge of circuits underlying asymmetry from flies to mammals has proven more challenging than expected. Several experimental approaches have been used to define asymmetry in mammalian systems, based on daughter cell fate, unequal partitioning of determinants and niche contacts, or proliferative potential. In this review, we aim to provide a critical evaluation of the assays used to establish the stem cell mode of division, with a particular focus on the mammary gland system. In this context, we will discuss the genetic alterations that impinge on the modality of stem cell division and their role in breast cancer development.

Indexed as

Asymmetric Cell DivisionMitosisAnimalsCell DifferentiationCell LineageDrosophilaDrosophila ProteinsHumansMammary Glands, HumanMiceNeoplasmsNeuronsSense OrgansStem Cell NicheStem CellsDrosophila Proteinsasymmetric cell division assaysasymmetric cell divisionsbreast cancermammary stem cells

Identifiers

PMID27872203
PMCPMC5283594
OpenAlexW2553568946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.